Syneron Medical Ltd (ELOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Sales | 298,102 | 277,849 | 255,750 | 256,915 | 263,620 |
| Cost of Goods | 142,469 | 128,884 | 119,771 | 126,838 | 127,180 |
| Gross Profit | 155,633 | 148,965 | 135,979 | 130,077 | 136,440 |
| Operating Expenses | 152,874 | 156,308 | 138,967 | 137,034 | 144,380 |
| Operating Income | 3,228 | -6,459 | -2,217 | -6,119 | -7,760 |
| Interest Expense | -764 | -167 | 688 | -26 | 270 |
| Other Income | 0 | 0 | 0 | 0 | 1,190 |
| Pre-tax Income | 3,992 | -6,292 | -2,905 | -6,093 | -6,840 |
| Income Tax | 3,813 | 48 | 2,295 | -7,640 | -4,500 |
| Net Income Continuous | 179 | -6,340 | -5,200 | 1,547 | 2,779 |
| Minority Interests | N/A | N/A | N/A | -100 | N/A |
| Net Income | $179 | $-6,340 | $-5,200 | $1,647 | $-2,340 |
| EPS Basic Total Ops | 0.01 | -0.17 | -0.14 | 0.04 | -0.04 |
| EPS Basic Continuous Ops | 0.01 | -0.17 | -0.14 | 0.04 | 0.08 |
| EPS Diluted Total Ops | 0.01 | -0.17 | -0.14 | 0.04 | -0.04 |
| EPS Diluted Continuous Ops | 0.01 | -0.17 | -0.14 | 0.04 | 0.08 |
| EPS Diluted Before Non-Recurring Items | 0.01 | 0.11 | 0.13 | 0.07 | 0.08 |
| EBITDA(a) | $11,675 | $2,506 | $6,066 | $4,353 | $3,220 |